罗欣药业：控股股东获1.3亿元增资完成工商登记

Group 1 - The core point of the article is that Luoxin Pharmaceutical announced an increase in capital by 130 million yuan from its controlling shareholder, Luoxin Holdings, which will raise its registered capital from 200 million yuan to 252 million yuan [1] - The new registered capital will consist of 52 million yuan, while four shareholders, including Liu Baoqi, have waived their subscription rights [1] - The capital increase has been officially registered, and Luoxin Holdings has obtained a new business license following the completion of the industrial and commercial change registration [1]